Abbott Laboratories buy UBS Group AG
Start price
20.04.23
/
50%
€102.04
Target price
20.04.24
€118.42
Performance (%)
-1.53%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. With a performance of -1.53%, the BUY prediction by UBS_Group_AG finished with a loss. A total of €1.96 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Abbott Laboratories | -2.090% | -2.090% | -2.671% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $117.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten